Molecular basis of Tousled-Like Kinase 2 activation-Reference-Cited by-同舟云学术

Molecular basis of Tousled-Like Kinase 2 activation

Published:2018-06-28 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Mortuza Gulnahar B.,Hermida Dario,Pedersen Anna-Kathrine,Segura-Bayona Sandra^ORCID,López-Méndez Blanca,Redondo Pilar^ORCID,Rüther Patrick^ORCID,Pozdnyakova Irina,Garrote Ana M.,Muñoz Inés G.,Villamor-Payà Marina,Jauset Cristina,Olsen Jesper V.^ORCID,Stracker Travis H.,Montoya Guillermo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-04941-y.pdf

Reference74 articles.

1. Deem, A. K., Li, X. & Tyler, J. K. Epigenetic regulation of genomic integrity. Chromosoma 121, 131–151 (2012).

2. Ransom, M., Dennehey, B. K. & Tyler, J. K. Chaperoning histones during DNA replication and repair. Cell 140, 183–195 (2010).

3. Luger, K., Mader, A. W., Richmond, R. K., Sargent, D. F. & Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251–260 (1997).

4. Burgess, R. J. & Zhang, Z. Histone chaperones in nucleosome assembly and human disease. Nat. Struct. Mol. Biol. 20, 14–22 (2013).

5. Le, S., Davis, C., Konopka, J. B. & Sternglanz, R. Two new S-phase-specific genes from Saccharomyces cerevisiae. Yeast 13, 1029–1042 (1997).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel approach to investigate the combinatorial effects of TLK1 (Tousled-Like Kinase1) inhibitors with Temozolomide for glioblastoma therapy;Bioorganic Chemistry;2024-10

2. Case report: A novel TLK2 variant with a neuropsychiatric phenotype from a Chinese family;Frontiers in Genetics;2024-09-04

3. The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β–mediated AML progression;Blood;2024-06-27

4. De novo TLK1 and MDM1 mutations in a patient with a neurodevelopmental disorder and immunodeficiency;iScience;2024-06

5. Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships;European Journal of Medicinal Chemistry;2024-05